Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Inventory (2016 - 2026)

Biomerica's Inventory history spans 16 years, with the latest figure at $2.0 million for Q1 2026.

  • On a quarterly basis, Inventory rose 23.44% to $2.0 million in Q1 2026 year-over-year; TTM through Feb 2026 was $2.0 million, a 23.44% increase, with the full-year FY2025 number at $1.5 million, down 37.29% from a year prior.
  • Inventory hit $2.0 million in Q1 2026 for Biomerica, up from $1.5 million in the prior quarter.
  • Over the last five years, Inventory for BMRA hit a ceiling of $3.3 million in Q2 2022 and a floor of $1.5 million in Q2 2025.
  • Historically, Inventory has averaged $2.2 million across 5 years, with a median of $2.1 million in 2023.
  • Biggest five-year swings in Inventory: rose 28.61% in 2024 and later crashed 37.29% in 2025.
  • Tracing BMRA's Inventory over 5 years: stood at $2.1 million in 2022, then grew by 13.46% to $2.3 million in 2023, then fell by 3.46% to $2.3 million in 2024, then crashed by 32.51% to $1.5 million in 2025, then soared by 34.06% to $2.0 million in 2026.
  • Business Quant data shows Inventory for BMRA at $2.0 million in Q1 2026, $1.5 million in Q4 2025, and $2.0 million in Q3 2025.